This review discusses the treatment of primary, nonmetastatic HER2-positive breast cancer in the adjuvant and neoadjuvant settings-settings in which tremendous progress has been made.
Zoneddy Dayao, MD
Advertisement
Articles by Zoneddy Dayao, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Data Readouts to Watch at the 2026 ASCO Annual Meeting
2
Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer
3
Outlining Exercise as a “Biologically Interventional Therapy” for Cancer
4
Navigating The Dynamic Landscape of Stem Cell Transplantation
5